Kathy Giusti

Giusti held executive positions in consumer marketing with Gillette/Procter & Gamble{{citation needed|date=October 2024}} and in the pharmaceutical sector with Merck & Co. and G.D. Searle & Company (now Pfizer).

In 1998, with her identical twin sister Karen Andrews, Giusti founded the Multiple Myeloma Research Foundation (the MMRF). The MMRF’s mission is to accelerate a cure for multiple myeloma patients.

As founder and CEO, Giusti has led the MMRF in establishing the Multiple Myeloma Research Consortium (MMRC), the MMRF CoMMpass™ study,{{Cite web |date=24 April 2014 |title=Giving hope and inspiration to cancer patients around the globe |url=https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=3396 |access-date=2021-02-19 |website=www.alumni.hbs.edu}} CureCloud,{{Cite web|last=MMRF|date=2020-07-14|title=MMRF Launches CureCloud to Democratize Healthcare for Cancer Patients|url=https://themmrf.org/2020/07/14/mmrf-launches-curecloud-to-democratize-healthcare-for-cancer-patients/|archive-url=https://web.archive.org/web/20200806130239/https://themmrf.org/2020/07/14/mmrf-launches-curecloud-to-democratize-healthcare-for-cancer-patients/|url-status=dead|archive-date=August 6, 2020|access-date=2021-02-19|website=themmrf.org|language=en-US}} the Right Track,{{Cite magazine |last1=Giusti |first1=Kathy |last2=Marcus |first2=Lori Tauber |date=12 February 2019 |title=4 Important Steps to Take After a Cancer Diagnosis |url=https://time.com/5525656/cancer-diagnosis-what-to-do/ |access-date=2021-02-19 |magazine=Time}}{{Primary source inline|date=October 2024}} and the Myeloma Investment Fund.{{Cite web|last=MMRF|date=2019-04-23|title=Multiple Myeloma Research Foundation (MMRF) Launches Innovative Fund to Accelerate New Myeloma Treatments|url=https://themmrf.org/2019/04/23/multiple-myeloma-research-foundation-mmrf-launches-innovative-fund-to-accelerate-new-myeloma-treatments/|archive-url=https://web.archive.org/web/20201024151318/https://themmrf.org/2019/04/23/multiple-myeloma-research-foundation-mmrf-launches-innovative-fund-to-accelerate-new-myeloma-treatments/|url-status=dead|archive-date=October 24, 2020|access-date=2021-02-19|website=themmrf.org|language=en-US}}

Under Giusti the MMRF has raised more than $500 million to fund research, 15 drugs have been approved to treat multiple myeloma, and many clinical trials are underway.{{Cite web|last=MMRF|date=2020-12-04|title=The MMRF Drives Unparalleled Advances for Multiple Myeloma Patients|url=https://themmrf.org/2020/12/04/the-mmrf-drives-unparalleled-advances-for-multiple-myeloma-patients/|archive-url=https://web.archive.org/web/20210126172339/https://themmrf.org/2020/12/04/the-mmrf-drives-unparalleled-advances-for-multiple-myeloma-patients/|url-status=dead|archive-date=January 26, 2021|access-date=2021-02-19|website=themmrf.org|language=en-US}} These efforts have accelerated the pace at which treatments are brought to patients and more than tripled patients' survival.

Giusti joined the Harvard Business School faculty as Senior Fellow, Co-Chairing the HBS Kraft Precision Medicine Accelerator, a $20 million endowed program provided by Robert Kraft and the Kraft Family Foundation. The Kraft Accelerator created The Kraft Precision Medicine Accelerator Playbook for Cures.{{Cite web |title=Use the Tools |url=https://www.hbs.edu/kraft-accelerator/use-the-tools.html |access-date=2021-02-19 |website=www.hbs.edu}}{{Primary source inline|date=October 2024}}

In 1996, Kathy Giusti was diagnosed with multiple myeloma, an incurable blood cancer. When diagnosed, Giusti was 37 years old and was given three years to live.{{Cite web |last=Kincaid |first=Ellie |date=2018-03-26 |title=She Was Given Three Years To Live. So She Transformed Cancer Research |url=https://www.forbes.com/sites/elliekincaid/2018/03/26/cancers-transformer/ |access-date=2021-02-19 |website=Forbes |language=en}} In 2022, Giusti was diagnosed with early-stage breast cancer as well.{{Cite web|last=Giusti|first=Kathy|title=I've Been Diagnosed With Two Different Cancers—This Is What I've Learned|url=https://www.prevention.com/health/a40187689/kathy-giusti-cancer/|access-date=2022-06-17|website=Prevention|date=17 June 2022 |language=en}}Giusti

Giusti has been appointed to multiple positions and advisory boards, all with a focus on developing cures for cancer. These include:

• National Cancer Advisory Board (NCAB)
• National Institutes of Health All of US Research Program/Precision Medicine Initiative (PMI) Working Group{{Cite web |date=2020-08-27 |title=Kathy Giusti, M.B.A. |url=https://allofus.nih.gov/about/who-we-are/pmi-working-group-advisory-committee-director/kathy-giusti-mba |access-date=2021-02-19 |website=National Institutes of Health (NIH) |language=en}}{{Primary source inline|date=October 2024}}
• Faster Cures Advisory Board Changemakers{{Cite web|title=FasterCures Changemakers: Disruptive Philanthropy for Patients|url=https://milkeninstitute.org/centers/fastercures/fastercures-changemakers-disruptive-philanthropy-for-patients|archive-url=https://web.archive.org/web/20200814201352/https://milkeninstitute.org/centers/fastercures/fastercures-changemakers-disruptive-philanthropy-for-patients|url-status=dead|archive-date=August 14, 2020|access-date=2021-02-19|website=milkeninstitute.org|language=en}}
• IMS Board{{Cite web|title=Multiple Myeloma Research Foundation (MMRF) Founder, CEO Receives American Society of Clinical Oncology's Partners In Progress Award|url=https://www.biospace.com/article/multiple-myeloma-research-foundation-mmrf-founder-ceo-receives-american-society-of-clinical-oncology-s-partners-in-progress-award-/|access-date=2021-02-19|website=BioSpace|language=en-US}}{{Dead link|date=October 2024}}
• EQRx Board{{Cite web|date=2021-09-27|title=EQRx Appoints Kathy Giusti to Board of Directors|url=https://www.eqrx.com/press-release/eqrx-appoints-kathy-giusti-to-board-of-directors/|archive-url=https://web.archive.org/web/20210927194051/https://www.eqrx.com/press-release/eqrx-appoints-kathy-giusti-to-board-of-directors/|url-status=dead|archive-date=September 27, 2021|access-date=2021-09-27|website=EQRx|language=en}}

Giusti has received numerous awards for her leadership:  

• Named one of Time magazine's 100 Most Influential People in the world
• Ranked #19 on Fortune's list of Worlds' 50 Greatest Leaders
• Recognized as 1 of 34 leaders changing healthcare by Fortune magazine{{Cite web|title=34 Leaders Who Are Changing Health Care|url=https://fortune.com/2017/04/20/digital-health-care-leaders/|access-date=2021-02-19|website=Fortune|language=en}}
• Named an Open Science Champion of Change by the White House{{Cite web |last=Giusti |first=Kathy |date=2013-06-20 |title=Democratizing the Science, Accelerating the Cure |url=https://obamawhitehouse.archives.gov/blog/2013/06/20/democratizing-science-accelerating-cure |access-date=2021-02-19 |website=whitehouse.gov |language=en}}
• Presented the Harvard Business School Alumni Achievement Award{{Cite web |date=January 2009 |title=Kathryn E. Giusti, MBA 1985 |url=https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=1988 |access-date=2021-02-19 |website=www.alumni.hbs.edu}}
• Received the Leadership in Personalized Medicine Award by the Personalized Medicine Coalition.{{Cite web|title=Personalized Medicine Coalition - Advocates for precision medicine : PMC Press Releases : Press Releases : Personalized Medicine Coalition Recognizes Kathy Giusti with Award for Leadership|url=http://www.personalizedmedicinecoalition.org/News/Press_Releases/Personalized_Medicine_Coalition_Recognizes_Kathy_Giusti_with_Award_for_Leadership|archive-url=https://web.archive.org/web/20150318051133/http://www.personalizedmedicinecoalition.org/News/Press_Releases/Personalized_Medicine_Coalition_Recognizes_Kathy_Giusti_with_Award_for_Leadership|url-status=dead|archive-date=March 18, 2015|access-date=2021-02-19|website=www.personalizedmedicinecoalition.org|language=en}}
• Presented the 2021 American Association for Cancer Research Distinguished Public Service Award{{Cite web |date=2021-04-05 |title=Giusti, Pelosi, and Sawyers to Receive American Association for Cancer Research Distinguished Public Service Awards {{!}} News Releases |url=https://www.aacr.org/about-the-aacr/newsroom/news-releases/giusti-pelosi-and-sawyers-to-receive-american-association-for-cancer-research-distinguished-public-service-awards/ |access-date=2021-04-21 |website=American Association for Cancer Research (AACR) |language=en}}{{Primary source inline|date=October 2024}}
• Named the Healthcare Businesswomen's Association's Woman of the Year Award{{Cite web|title=Woman of the Year Past Recipients {{!}} HBA|url=https://www.hbanet.org/woman-of-the-year-past-recipients|archive-url=https://web.archive.org/web/20150522162440/http://www.hbanet.org/woman-of-the-year-past-recipients|url-status=dead|archive-date=May 22, 2015|access-date=2021-02-19|website=www.hbanet.org}}

Kathy has authored or co-authored multiple articles in business, consumer, and scientific publications:

• [https://hbr.org/2022/06/reducing-racial-disparities-in-cancer-treatment-demands-collective-action Reducing Racial Disparities in Cancer Treatment Demands Collective Action], Harvard Business Review{{Cite news|date=2022-06-13|title=Reducing Racial Disparities in Cancer Treatment Demands Collective Action|work=Harvard Business Review|url=https://hbr.org/2022/06/reducing-racial-disparities-in-cancer-treatment-demands-collective-action|access-date=2022-06-13}}
• [https://hbr.org/2022/01/reducing-racial-disparities-in-cancer-outcomes Reducing Racial Disparities in Cancer Outcomes], Harvard Business Review{{Cite news|date=2022-01-17|title=Reducing Racial Disparities in Cancer Outcomes|work=Harvard Business Review|url=https://hbr.org/2022/01/reducing-racial-disparities-in-cancer-outcomes|access-date=2022-01-17}}
• [https://hbr.org/2021/06/addressing-demographic-disparities-in-clinical-trials?ab=hero-subleft-3 Addressing Demographic Disparities in Clinical Trials], Harvard Business Review{{Cite news|date=2021-06-11|title=Addressing Demographic Disparities in Clinical Trials|work=Harvard Business Review|url=https://hbr.org/2021/06/addressing-demographic-disparities-in-clinical-trials|access-date=2021-06-21|issn=0017-8012}}
• [https://www.thejournalofprecisionmedicine.com/a-new-playbook-for-cure-seeking-nonprofits/ A New Playbook for Cure-Seeking Nonprofits], Journal of Precision Medicine{{Cite web|title=A New Playbook for Cure-Seeking Nonprofits|url=https://www.thejournalofprecisionmedicine.com/a-new-playbook-for-cure-seeking-nonprofits/|access-date=2021-02-19|website=The Journal of Precision Medicine|language=en-us}}
• [https://hbr.org/2020/09/how-nonprofit-foundations-can-sustainably-fund-disease-research How Nonprofit Foundations Can Sustainably Fund Disease Research], Harvard Business Review{{Cite news|date=2020-09-30|title=How Nonprofit Foundations Can Sustainably Fund Disease Research|work=Harvard Business Review|url=https://hbr.org/2020/09/how-nonprofit-foundations-can-sustainably-fund-disease-research|access-date=2021-02-19|issn=0017-8012}}
• [https://hbr.org/2020/08/what-it-takes-to-lead-a-disease-research-foundation What It Takes to Lead a Disease Research Foundation], Harvard Business Review{{Cite news|date=2020-08-18|title=What It Takes to Lead a Disease Research Foundation|work=Harvard Business Review|url=https://hbr.org/2020/08/what-it-takes-to-lead-a-disease-research-foundation|access-date=2021-02-19|issn=0017-8012}}
• [https://hbr.org/2020/03/how-medical-nonprofits-set-winning-strategy How Medical Nonprofits Set Winning Strategy], Harvard Business Review^[{{Cite news|date=2020-03-06|title=How Medical Nonprofits Set Winning Strategy|work=Harvard Business Review|url=https://hbr.org/2020/03/how-medical-nonprofits-set-winning-strategy|access-date=2021-02-19|issn=0017-8012}}
• [https://hbr.org/2016/11/one-obstacle-to-curing-cancer-patient-data-isnt-shared One Obstacle to Curing Cancer: Patient Data Isn’t Shared], Harvard Business Review{{Cite news|date=2016-11-28|title=One Obstacle to Curing Cancer: Patient Data Isn't Shared|work=Harvard Business Review|url=https://hbr.org/2016/11/one-obstacle-to-curing-cancer-patient-data-isnt-shared|access-date=2021-02-19|issn=0017-8012}}
• [https://hbr.org/2017/01/what-cancer-researchers-can-learn-from-direct-to-consumer-companies What Cancer Researchers Can Learn from Direct-to-Consumer Companies], Harvard Business Review{{Cite news|date=2017-01-12|title=What Cancer Researchers Can Learn from Direct-to-Consumer Companies|work=Harvard Business Review|url=https://hbr.org/2017/01/what-cancer-researchers-can-learn-from-direct-to-consumer-companies|access-date=2021-02-19|issn=0017-8012}}
• [https://pubmed.ncbi.nlm.nih.gov/29794540/ Closing Knowledge Gaps to Optimize Patient Outcomes and Advance Precision Medicine], Cancer Journal{{Cite journal|last1=Giusti|first1=Kathy|last2=Young|first2=Anne Quinn|last3=Lehrhaupt|first3=Kerri|date=May–June 2018|title=Closing Knowledge Gaps to Optimize Patient Outcomes and Advance Precision Medicine|url=https://pubmed.ncbi.nlm.nih.gov/29794540/|journal=Cancer Journal (Sudbury, Mass.)|volume=24|issue=3|pages=144–151|doi=10.1097/PPO.0000000000000319|issn=1540-336X|pmid=29794540|s2cid=44094784 }}
• [https://www.gotoper.com/publications/ajho/2017/2017mar/understanding-differences-in-critical-decisions-in-the-multiple-myeloma-patient-journey-in-the-era-of-precision-medicine Understanding Differences in Critical Decisions in the Multiple Myeloma Patient Journey in the Era of Precision Medicine], American Journal of Hematology/Oncology{{Cite journal|last1=Giusti|first1=Kathy|last2=Young|first2=Anne Quinn|last3=Winget|first3=Melissa|last4=Lehrhaupt|first4=and Kerri|date=2017-04-11|title=Understanding Differences in Critical Decisions in the Multiple Myeloma Patient Journey in the Era of Precision Medicine|url=https://www.gotoper.com/publications/ajho/2017/2017mar/understanding-differences-in-critical-decisions-in-the-multiple-myeloma-patient-journey-in-the-era-of-precision-medicine|journal=American Journal of Hematology/Oncology|volume=13|issue=3}}

• [https://kathygiusti.com/ KathyGiusti.com]
• [http://www.themmrf.org/ MMRF website]
• [http://www.hbs.edu/healthcare/faculty/kraft-accelerator/Pages/default.aspx Kraft HBS Precision Medicine Accelerator website]

{{DEFAULTSORT:Giusti, Kathy}}

Category:1958 births

Category:Living people

Category:American health care businesspeople

Category:American health care chief executives

Category:Harvard Business School alumni

Category:Identical twin females

Category:People with multiple myeloma

Category:People from Connecticut

Category:University of Vermont alumni

Category:Cancer researchers

Category:American identical twins

Category:American women chief executives

Category:American nonprofit chief executives

Category:21st-century American women